« Back to Record
Lacaze-Masmonteil, T., Seidenberg, J., Mitchell, I., Cossey, V., Cihar, M., Csader, M., Baarsma, R., Valido, M., Pollack, P. P., Groothuis, J. J., Allegaert, K., Lombet, J., Haumont, D., Plaskie, K., Davies, D. D. H., Sauve, R. R., Langley, J. J., Liska, K., Andre, P., Lequien, P., Kacet, N., Lapeyre, F., Wickenburg-Ennen, B., Nolte, H., Harding, P. A., Ramos, S., Carolino, M., & Marques, A. (2003). Evaluation of the safety of palivizumab in the second season of exposure in young children at risk for severe respiratory syncytial virus infection. Drug safety, 26(4), 283-291. doi:10.2165/00002018-200326040-00005
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/191302



